(Q40942293)

25 September 2017

1 reference

title

Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy (English)

1 reference

25 September 2017

1 reference

1 reference

1

Fountzilas G

1 reference

25 September 2017

Gossios K

2

1 reference

25 September 2017

Zisiadis A

3

1 reference

25 September 2017

Svarna E

4

1 reference

25 September 2017

Skarlos D

5

1 reference

25 September 2017

Pavlidis N

6

1 reference

25 September 2017

language of work or name

1 reference

1 May 1996

1 reference

25 September 2017

published in

Pediatric Blood Cancer

1 reference

25 September 2017

volume

26

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

305-317

1 reference

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Original article: Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: A randomized trial of the Italian Oncology Group for Clinical Research (GOIRC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Fluorouracil as monotherapy or combined with folinic acid in the treatment of metastasizing colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Survival and response to chemotherapy for advanced colorectal adenocarcinoma: an Eastern Cooperative Oncology Group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Determinants of survival after intraarterial infusion of 5-fluorouracil for liver metastases from colorectal cancer: a multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Determinants of survival in patients with unresectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Natural history of patients with untreated liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199605%2926%3A5%3C305%3A%3AAID-MPO2%3E3.0.CO%3B2-M

10.1002/(SICI)1096-911X(199605)26:5<305::AID-MPO2>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference